Adjuvants suffer politics

The science of vaccine supply-stretching adjuvants--approved and used in some European countries--appears to be getting overwhelmed by political concerns about their safety. Fear mongering has stalled their use in the U.S. Interview

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.